These donor-recipient signaling networks, impossible in native lung diseases, define CLAD as a disease of cellular miscommunication with specific therapeutic targets (HGF-MET, TRAIL, PD-L1/PD-1) for interrupting progression. Here, MET is linked to lung disorder.